drugset

drugset / Trial / NCT00197080

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

NCT00197080 ↗

Phase 3 Completed 380 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of ropinirole XR in the treatment of adults with Restless Legs Syndrome (RLS).

Timeline

Start: 2005-06
Primary completion: —
Completion: 2006-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropinirole	Small molecule	—	—

Indications